Jaume Campistol

1.2k total citations
19 papers, 237 citations indexed

About

Jaume Campistol is a scholar working on Molecular Biology, Clinical Biochemistry and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jaume Campistol has authored 19 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Clinical Biochemistry and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jaume Campistol's work include Metabolism and Genetic Disorders (6 papers), Mitochondrial Function and Pathology (3 papers) and Epilepsy research and treatment (3 papers). Jaume Campistol is often cited by papers focused on Metabolism and Genetic Disorders (6 papers), Mitochondrial Function and Pathology (3 papers) and Epilepsy research and treatment (3 papers). Jaume Campistol collaborates with scholars based in Spain, France and Germany. Jaume Campistol's co-authors include V. Cusí, Antònia Ribes, S. Rubí, Paz Briones, Javier Aparicio, Anna Calvo, Françesca Pons, Jordi Rumià, Mar Carreño and Xavier Setoaín and has published in prestigious journals such as SHILAP Revista de lepidopterología, Epilepsia and Developmental Medicine & Child Neurology.

In The Last Decade

Jaume Campistol

19 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jaume Campistol Spain 9 103 77 61 51 35 19 237
Martino Montomoli Italy 8 166 1.6× 87 1.1× 31 0.5× 75 1.5× 23 0.7× 11 299
Asif Paker United States 5 116 1.1× 58 0.8× 23 0.4× 31 0.6× 19 0.5× 9 193
Bregje Jaeger Netherlands 9 80 0.8× 95 1.2× 26 0.4× 12 0.2× 57 1.6× 22 216
Suresh Vijay United Kingdom 9 68 0.7× 73 0.9× 40 0.7× 23 0.5× 79 2.3× 31 337
Jaina Patel Canada 8 118 1.1× 125 1.6× 37 0.6× 109 2.1× 91 2.6× 17 389
Zvonka Rener‐Primec Slovenia 9 53 0.5× 21 0.3× 77 1.3× 67 1.3× 24 0.7× 20 231
Sharon Samueli Austria 9 70 0.7× 143 1.9× 48 0.8× 128 2.5× 10 0.3× 16 353
Emma Glamuzina New Zealand 11 148 1.4× 149 1.9× 61 1.0× 9 0.2× 76 2.2× 30 323
Junko Muroi Japan 12 228 2.2× 168 2.2× 79 1.3× 21 0.4× 26 0.7× 19 439
Andrea Guerin Canada 8 99 1.0× 32 0.4× 69 1.1× 19 0.4× 24 0.7× 30 336

Countries citing papers authored by Jaume Campistol

Since Specialization
Citations

This map shows the geographic impact of Jaume Campistol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaume Campistol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaume Campistol more than expected).

Fields of papers citing papers by Jaume Campistol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jaume Campistol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaume Campistol. The network helps show where Jaume Campistol may publish in the future.

Co-authorship network of co-authors of Jaume Campistol

This figure shows the co-authorship network connecting the top 25 collaborators of Jaume Campistol. A scholar is included among the top collaborators of Jaume Campistol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaume Campistol. Jaume Campistol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Aparicio, Javier, Aida Niñerola‐Baizán, Andrés Perissinotti, et al.. (2022). Presurgical evaluation of drug-resistant paediatric focal epilepsy with PISCOM compared to SISCOM and FDG-PET. Seizure. 97. 43–49. 4 indexed citations
2.
Ortigoza‐Escobar, Juan Darío, Cristina Jou, Laura Gort, et al.. (2022). Leigh syndrome is the main clinical characteristic of PTCD3 deficiency. Brain Pathology. 33(3). e13134–e13134. 8 indexed citations
3.
Navarro‐Sastre, Aleix, Frederic Tort, Judit García‐Villoria, et al.. (2012). Mitochondrial DNA depletion syndrome: New descriptions and the use of citrate synthase as a helpful tool to better characterise the patients. Molecular Genetics and Metabolism. 107(3). 409–415. 24 indexed citations
4.
Campistol, Jaume, et al.. (2012). Neurological dysfunction induced by bilirrubin. SHILAP Revista de lepidopterología. 27(4). 202–211. 1 indexed citations
5.
Font, Aida, Aleix Navarro‐Sastre, Leslie Matalonga, et al.. (2012). Protein expression profiles in patients carrying NFU1 mutations. Contribution to the pathophysiology of the disease. Journal of Inherited Metabolic Disease. 36(5). 841–847. 27 indexed citations
6.
Rubí, S., Xavier Setoaín, Antonio Donaire, et al.. (2011). Validation of FDG-PET/MRI coregistration in nonlesional refractory childhood epilepsy. Epilepsia. 52(12). 2216–2224. 60 indexed citations
7.
Campistol, Jaume, et al.. (2010). Disfunción neurológica inducida por bilirrubina. Neurología. 27(4). 202–211. 11 indexed citations
8.
Gort, Laura, Irene Madrigal, Cristina Fernández, et al.. (2010). X-inactivation of HSD17B10 revealed by cDNA analysis in two female patients with 17β-hydroxysteroid dehydrogenase 10 deficiency. European Journal of Human Genetics. 18(12). 1353–1355. 9 indexed citations
9.
Gort, Laura, Irene Madrigal, Cristina Fernández, et al.. (2010). Reply to He et al. European Journal of Human Genetics. 19(2). 124–124. 1 indexed citations
10.
Herranz, J L, et al.. (2006). Eficacia y tolerabilidad del levetiracetam en 133 niños con crisis epilépticas farmacorresistentes. Revista de Neurología. 43(7). 393–393. 4 indexed citations
11.
Urreizti, Roser, Susana Balcells, Laura Vilarinho, et al.. (2003). Spectrum of CBS mutations in 16 homocystinuric patients from the Iberian Peninsula: High prevalence of T191M and absence of I278T or G307S. Human Mutation. 22(1). 103–103. 23 indexed citations
12.
Vilaseca, Marta, K. Kobayashi, P. Briones, et al.. (2001). Phenotype and Genotype Heterogeneity in Mediterranean Citrullinemia. Molecular Genetics and Metabolism. 74(3). 396–398. 15 indexed citations
13.
Campistol, Jaume. (2001). Parasagittal Cerebral Injury: Comments on a Letter. Journal of Child Neurology. 16(4). 299–299. 1 indexed citations
14.
Mallolas, Judith, Marina Vilaseca, Nilo Lambruschini, et al.. (2000). Large de novo deletion in chromosome 12 affecting the PAH, IGF1, ASCL1, and TRA1 genes. Journal of Molecular Medicine. 78(12). 721–724. 4 indexed citations
15.
Busquets, C., María Josep Coll, E. Christensen, et al.. (1998). Feasibility of molecular prenatal diagnosis of glutaric aciduria type I in chorionic villi. Journal of Inherited Metabolic Disease. 21(3). 243–246. 5 indexed citations
16.
Pineda, Mercè, Jaume Campistol, Marina Vilaseca, et al.. (1995). An atypical French form of pyruvate carboxylase deficiency. Brain and Development. 17(4). 276–279. 15 indexed citations
17.
Campistol, Jaume, E Fernández-Álvarez, & J. Ruscalleda. (1987). CT appearance of low attenuation areas in basal ganglia in childhood: Report of 23 cases. Computerized Radiology. 11(5-6). 229–235. 4 indexed citations
18.
Campistol, Jaume, et al.. (1986). Dystonia as a presenting sign of subacute necrotising encephalomyelopathy in infancy. European Journal of Pediatrics. 144(6). 589–591. 5 indexed citations
19.
Campistol, Jaume, et al.. (1984). CT Scan Appearance in Subacute Necrotising Encephalo‐myelopathy. Developmental Medicine & Child Neurology. 26(4). 519–522. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martino Montomoli Breakdown of academic impact, for papers by Asif Paker Breakdown of academic impact, for papers by Bregje Jaeger Breakdown of academic impact, for papers by Suresh Vijay Breakdown of academic impact, for papers by Jaina Patel Breakdown of academic impact, for papers by Zvonka Rener‐Primec Breakdown of academic impact, for papers by Sharon Samueli Breakdown of academic impact, for papers by Emma Glamuzina Breakdown of academic impact, for papers by Junko Muroi Breakdown of academic impact, for papers by Andrea Guerin
Rankless by CCL
2026